What the media is reporting about MassBio
News from the biotechnology industry
Showing news: 211–220 of 492
October 23, 2012 —
Below is information on how to submit written testimony on the Pharmaceutical and Medical Device Manufacturer Conduct (Gift Ban) regulations:
The Department encourages all interested parties to submit testimony electronically to the following…
October 19, 2012 —
Floyd E. Bloom, MD - Founder, Alkermes, Inc. and emeritus Professor at the Scripps Research Institute
Dr. Bloom is a founder and director of Alkermes Corporation. He is currently a member of the President’s Council on Bioethics and is professor…
October 10, 2012 —
Why I support the MassBioEd FoundationBy Joshua Boger, Ph.D.
Without the talented, trained workforce here in Massachusetts, Vertex Pharmaceuticals would not be the company it is today. That's why I am asking you to join me to support STEM…
October 10, 2012 —
MassCONNECT mentor program pairs new entrepreneurs with seasoned pros to advance ideas
October 10, 2012 (CAMBRIDGE, MA) —Entrepreneurs working on diagnostics to measure prostate tumors’ aggressiveness, the half-life of potentially…
October 5, 2012 —
The 2012 Massachusetts-Israel Innovation Partnership (MIIP) program is now open. Applications can be submitted online via the Center's website, with a Phase 1 application deadline of December 7, 2012 at noon EST.
Launched in June 2011, MIIP…
September 26, 2012 —
Washington, DC; Carlsbad, CA and Boston, MA – September 26, 2012: The fifth annual international partnering conference, BioPharm America™ 2012, wrapped up last week in Boston. There were over 750 delegates representing 462 companies from…
September 25, 2012 —
The Massachusetts Life Sciences Center (MLSC) is pleased to announce the launch of the first Request for Proposals (RFP) funded by seven global biopharmaceutical companies that comprise the Massachusetts Neuroscience Consortium (the…
September 19, 2012 —
Eight of the companies named to this year’s Fierce 15 list are based in Massachusetts, another harbinger of the biotech industry’s strength in the Commonwealth.
FierceBiotech, the biotech industry’s daily monitor, announced the 2012 Fierce 15…
September 18, 2012 —
Oslo, Norway, 18 September 2012 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of the offices and facilities of Algeta US in Cambridge, Massachusetts.
September 13, 2012 —
Annual statistics show Commonwealth outpacing other clusters for growth in employment, investment
Massachusetts jobs in biotechnology research and development grew faster than in any other state in the nation and Massachusetts is home to more…